Design Therapeutics, Inc.

DSGN

Design Therapeutics, Inc.

DSGN

Insider Sentiment (TTM):

Last Purchase:2024-03-25Last Sale:2025-08-13Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:37,135,655Shares Outstanding:61,434,457Institutional Ownership Pct.:60.45%

Earnings Market Reaction:

Filing Date:2026-08-03Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	13	13	17	15	20	14	23	30	46	29	21	28
Marketable Securities Current	194	210	203	191	197	216	223	224	215	241	261	263
Prepaid Expense And Other Assets Current	5	4	4	3	4	4	3	3	4	3	3	4
Assets Current	212	227	224	209	220	234	248	257	265	274	285	295
Property Plant And Equipment Net	1	1	1	1	1	1	1	2	2	2	2	2
Operating Lease Right Of Use Asset	2	3	1	2	2	2	2	2	3	3	3	3
Other Assets	-	-	0	0	0	0	0	0	0	0	0	0
Assets	215	230	226	212	223	237	252	262	270	279	290	300
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	3	2	2	2	1	3	2	1	1	1	2	2
Accounts Payable And Other Accrued Liabilities Cur…	8	8	11	9	8	5	6	6	5	6	8	10
Liabilities Current	11	10	13	11	9	8	8	7	6	7	10	12
Operating Lease Liability Noncurrent	2	2	1	1	1	1	2	2	2	2	2	3
Liabilities	13	12	14	12	10	10	10	9	8	9	12	15
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	537	533	509	480	477	472	469	465	462	458	455	452
Retained Earnings Accumulated Deficit	-335	-315	-297	-281	-264	-245	-227	-214	-201	-189	-178	-166
Accumulated Other Comprehensive Income Loss Net Of…	-1	-0	0	0	0	0	0	1	-0	-0	0	-1
Stockholders Equity	202	218	213	200	213	228	242	252	261	270	278	285
Liabilities And Stockholders Equity	215	230	226	212	223	237	252	262	270	279	290	300
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	63	62	60	57	57	57	57	57	57	56	56	56
Shares Outstanding	63	62	60	57	57	57	57	57	57	56	56	56

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-14.36%	-2.89%	-1.87%	-	-	-	-	-	-	-	-	-
2025	12.01%	7.21%	20.72%	39.29%	65.49%	44.33%	43.36%	47.02%	55.42%	8.29%	28.25%	1.06%
2024	-13.65%	-28.57%	11.94%	1.93%	14.38%	16.74%	3.63%	7.94%	-14.16%	-30.18%	-4.52%	-23.41%
2023	-	-	-	-63.85%	-68.62%	-70.12%	18.54%	22.93%	16.10%	42.47%	76.45%	48.65%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	18.86	22.28	17.14	18.71	25.13	28.37	29.31	34.61	41.42	38.61	29.58	23.77
Quick Ratio	18.45	21.87	16.84	18.43	24.73	27.89	29.01	34.19	40.82	38.16	29.29	23.48
Working Capital	200.77M	216.86M	210.73M	197.86M	211.05M	225.41M	239.58M	249.81M	258.45M	266.79M	274.96M	282.15M
Leverage & Debt
Debt to Equity	0.07	0.06	0.06	0.06	0.05	0.04	0.04	0.04	0.03	0.03	0.04	0.05
Debt Ratio	0.06	0.05	0.06	0.06	0.04	0.04	0.04	0.04	0.03	0.03	0.04	0.05
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-1.13	-1.13	-1.22	-1.18	-1.12	-0.99	-0.88	-0.84	-0.89	-1.04	-1.19	-1.29
Free Cash Flow Per Share TTM	-0.89	-0.88	-0.95	-0.62	-0.60	-0.84	-0.77	-0.82	-0.91	-0.95	-1.05	-1.10
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	11.51%	24.05%	40.74%	41.16%	25.65%	-4.22%	-25.84%	-33.97%	-31.97%	-15.38%	5.61%	26.87%
EPS Growth (1Y)	1.44%	14.61%	38.92%	40.34%	24.98%	-4.67%	-26.62%	-34.71%	-32.70%	-16.25%	5.09%	26.41%
Valuation Metrics
P/E TTM	-12.78	-9.38	-7.71	-6.36	-3.02	-3.90	-7.04	-6.38	-3.75	-3.88	-2.22	-1.83
P/B TTM	4.48	3.00	2.53	2.15	0.90	0.96	1.44	1.21	0.73	0.84	0.53	0.46
Market Cap	904.45M	653.66M	537.76M	428.84M	191.62M	219.09M	349.14M	304.62M	189.46M	227.65M	148.36M	132.13M
Enterprise Value	891.55M	640.89M	520.90M	413.75M	171.91M	205.42M	326.58M	274.29M	143.76M	198.25M	127.16M	104.19M
Calculated Values
Free Cash Flow TTM	-55.57M	-54.12M	-54.55M	-35.55M	-33.95M	-47.70M	-43.48M	-46.44M	-51.47M	-53.94M	-58.82M	-61.37M
Net Debt	-12.91M	-12.77M	-16.86M	-15.09M	-19.70M	-13.67M	-22.56M	-30.33M	-45.70M	-29.40M	-21.20M	-27.94M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-08-13Sale

Owner: William, Arsani

Title: -

Shares: 562,627

Price/Share: $5.25

Value: $2,953,791.75

Shares Owned: 1,000,000

Relationship: Director

Ownership: Indirect

2024-12-18Sale

Owner: Prasad, Deepa

Title: -

Shares: 3,806

Price/Share: $6.27

Value: $23,863.62

Shares Owned: 20,000

Relationship: Director

Ownership: Direct

2024-08-09Sale

Owner: William, Arsani

Title: -

Shares: 814,874

Price/Share: $4.25

Value: $3,463,214.50

Shares Owned: -

Relationship: Director

Ownership: Indirect

2024-03-25Purchase

Owner: Berger, Heather A.

Title: -

Shares: 1,300

Price/Share: $3.74

Value: $4,862.00

Shares Owned: 1,300

Relationship: Director

Ownership: Direct

2024-03-25Purchase

Owner: Schmid, John P.

Title: -

Shares: 17,809

Price/Share: $3.74

Value: $66,605.66

Shares Owned: 26,965

Relationship: Director

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-08-13	William, Arsani	Director	-	Indirect	Sale	562,627	5.25	$2,953,791.75	1,000,000	4
2024-12-18	Prasad, Deepa	Director	-	Direct	Sale	3,806	6.27	$23,863.62	20,000	4
2024-08-09	William, Arsani	Director	-	Indirect	Sale	814,874	4.25	$3,463,214.50	0	4
2024-03-25	Berger, Heather A.	Director	-	Direct	Purchase	1,300	3.74	$4,862.00	1,300	4
2024-03-25	Schmid, John P.	Director	-	Indirect	Purchase	17,809	3.74	$66,605.66	26,965	4
2023-09-29	Lappe, Rodney W	Director	-	Direct	Purchase	21,000	2.35	$49,350.00	133,024	4
2023-08-29	William, Arsani	Director	-	Indirect	Purchase	1,960,000	2.44	$4,782,400.00	3,000,000	4
2023-08-29	Prasad, Deepa	Director	-	Direct	Purchase	12,000	2.31	$27,720.00	23,806	4
2022-12-20	Sr, One Capital Partners …	TenPercentOwner	-	Direct	Purchase	40,000	8.14	$325,600.00	6,526,476	4
2022-12-20	Siffert, Joao Md	Director,Officer	President and CEO	Direct	Purchase	6,300	8.38	$52,794.00	132,619	4
2022-12-16	George, Simeon	Director,TenPercentOwner	-	Indirect	Purchase	500,000	8.28	$4,140,000.00	6,126,476	4
2022-12-09	Lappe, Rodney W	Director	-	Direct	Purchase	15,000	7.96	$119,400.00	112,024	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

60.45%

Inst. Shares: 37,135,655

Shares Outstanding: 61,434,457

2025-12-31

65.03%

Inst. Shares: 37,279,762

Shares Outstanding: 57,330,192

2025-09-30

59.39%

Inst. Shares: 33,825,940

Shares Outstanding: 56,950,999

2025-06-30

59.29%

Inst. Shares: 33,714,263

Shares Outstanding: 56,859,388

2025-03-31

59.25%

Inst. Shares: 33,628,194

Shares Outstanding: 56,757,827

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	37,135,655	61,434,457	60.45%
2025-12-31	37,279,762	57,330,192	65.03%
2025-09-30	33,825,940	56,950,999	59.39%
2025-06-30	33,714,263	56,859,388	59.29%
2025-03-31	33,628,194	56,757,827	59.25%
2024-12-31	32,573,784	56,587,142	57.56%
2024-09-30	31,051,507	56,620,731	54.84%
2024-06-30	31,134,886	56,555,960	55.05%
2024-03-31	29,469,946	56,488,527	52.17%
2023-12-31	30,530,741	55,984,670	54.53%
2023-09-30	32,436,779	55,988,691	57.93%
2023-06-30	38,133,923	55,948,990	68.16%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Design Therapeutics, Inc. (DSGN) — SEC Financial Statements & Analysis

Design Therapeutics, Inc. (DSGN) is a pharmaceutical preparations company, incorporated in DE. Design Therapeutics, Inc. trades on Nasdaq as: DSGN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Design Therapeutics, Inc. reported a Debt-to-Equity ratio of 0.07x, a Price-to-Book (P/B) ratio of 4.48x (TTM), at a market cap of $904.45M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.07x
P/B TTM: 4.48x
Market Cap: $904.45M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Design Therapeutics, Inc. in?

Design Therapeutics, Inc. (DSGN) operates in the Pharmaceutical Preparations industry.

What is DSGN's market cap?

Design Therapeutics, Inc. (DSGN) has a market capitalization of $904.45M as of 2026-06-30.

What exchange does DSGN trade on?

Design Therapeutics, Inc. (DSGN) trades on the Nasdaq.

Where is Design Therapeutics, Inc. incorporated?

Design Therapeutics, Inc. is incorporated in DE.